DYNAMICS OF PATHOMORPHOLOGICAL CHANGES OF THE MYOCARDIUM IN CHRONIC EXPERIMENTAL ENDOTOXICOSIS
Article PDF (Українська)

Keywords

lipopolysaccharide, endotoxicosis, dystrophic-sclerotic manifestations

Abstract views: 26
PDF Downloads: 15

How to Cite

Koval , D., Kolosovych, A., Levenets О., HladiyО., & Mykolenko, A. (2022). DYNAMICS OF PATHOMORPHOLOGICAL CHANGES OF THE MYOCARDIUM IN CHRONIC EXPERIMENTAL ENDOTOXICOSIS. Medical Science of Ukraine (MSU), 18(4), 8-13. https://doi.org/10.32345/2664-4738.4.2022.02

Abstract

Relevance. Modeling the conditions of endotoxicosis by introducing bacterial lipopolysaccharide against the background of toxic liver damage is due to the fact that under such conditions the situation that accompanies almost every chronic pathology, including cardiovascular, is reproduced. The release of substances that play a role in the formation of endogenous intoxication causes heart damage in the absence of cardiac pathology, and in its presence worsens the course and prognosis. However, it should be found out whether these changes are the result of only toxic damage to cardiomyocytes or have another morphological basis and what their dynamics are.

Objective: to characterize the morphological changes of the myocardium in experimental chronic endotoxicosis.

Materials and methods. The research was carried out by modeling endotoxicosis  in 18 laboratory animals for 90 days by daily intragastric injection of tetrachloromethane at the rate of 3-5 ml/kg of body weight and every 6th day by intraperitoneally adding bacterial lipopolysaccharide at a dose of 0.2 mg/kg of body weight. Animals were removed from the experiment by decapitation at 30, 60, and 90 days. Animals were removed from the experiment by decapitation after anesthesia with intraperitoneal administration of sodium thiopental at a dose of 50 mg/kg. The control group consisted of 6 intact animals. For histological examination, myocardial tissue was condensed in paraffin, and deparaffinized sections were stained with hematoxylin and eosin, examined for the detection of neutral glycosaminoglycans and acidic mucopolysaccharides, stained with Alcian blue and PAS-reaction according to standard methods, and examined under a Nikon Eclipse Ci-E light microscope.

Results. During researching the myocardium at the light-optical level of experimental animals, after 30 days of chronic endogenous intoxication caused by injection of tetrachloromethane and bacterial LPS, it undergoes changes, first of all, it concerned cardiomyocytes: we observe thinned cells around the vessels and unchanged ones at a distance from the vessels. In some of them, hyperchromia of the nuclei and phenomena of contractile damage and fiber fragmentation were noted. Manifestations from the CMC increased during the next period of the experiment: after 60 days, expressed wave-like deformation of fibers with atrophic changes in muscle cells was detected in the myocardium. Hemodynamic changes were characterized by hyperemia, the number of perivascular hemorrhages increased. On the 90th day of the experiment, in addition to inflammatory manifestations and dystrophic-necrotic changes, cardiomyocyte atrophy in combination with expressed interstitial edema was detected in the myocardial tissue of animals. In the stroma, in addition to small foci of perivascular cardiosclerosis, foci of adipocyte growth were determined. Cardiomyocyte defibrillation and hemorrhages were observed in some areas

Conclusion. The intensity of structural changes in cardiomyocytes and hemodynamic disorders in chronic endotoxicosis depends on the duration of intoxication and the character of structural changes. The interstitium of the myocardium of rats under experimental endotoxicosis conditions is dystrophic-sclerotic and is manifested by a different combination of edematous and sclerotic manifestations at different stages of exposure to toxicants.

https://doi.org/10.32345/2664-4738.4.2022.02
Article PDF (Українська)

References

Patel PN, Shah RY, Ferguson JF, Reilly MP. Human experimental endotoxemia in modeling the pathophysiology, genomics, and therapeutics of innate immunity in complex cardiometabolic diseases. Arteriosclerosis, Thrombosis, and Vascular Biology. 2015;35(3):525-534. DOI: 10.1161/ATVBAHA.114.304455

View at:

Publisher Site: https://www.ahajournals.org/doi/10.1161/ATVBAHA.114.304455

PubMed: https://pubmed.ncbi.nlm.nih.gov/25550206/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344396/

Leskelä J, Toppila I, Härma M, Palviainen T, Salminen A, Sandholm N, Pietiäinen M, Kopra E, Pais de Barros J, Lassenius MI, Kumar A, Harjutsalo V, Roslund K, Forsblom C, Loukola A, Havulinna AS, Lagrost L, Salomaa V, Groop P, Perola M, Kaprio J, Lehto M, Pussinen PJ. Genetic profile of endotoxemia reveals an association with thromboembolism and stroke. Journal of the American Heart Association. 2021;10(21):e022482. DOI: 10.1161/JAHA.121.022482

View at:

Publisher Site: https://www.ahajournals.org/doi/10.1161/JAHA.121.022482

PubMed: https://pubmed.ncbi.nlm.nih.gov/34668383/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751832/

Zila I, Mokra D, Kopincova J, Kolomaznik M, Javorka M, Calkovska A. Heart rate variability and inflammatory response in rats with lipopolysaccharide-induced endotoxemia. Physiological Research. 2015;(Suppl 5):S669-S676. DOI: 10.33549/physiolres.933226

View at:

Publisher Site: https://www.biomed.cas.cz/physiolres/2015/S5_15.htm

PubMed: https://pubmed.ncbi.nlm.nih.gov/26674290/

URL: http://www.biomed.cas.cz/physiolres/pdf/64%20Suppl%205/64_S669.pdf

Ikram MA, Brusselle G, Ghanbari M, Goedegebure A, Ikram MK, Kavousi M, Kieboom BCT, Klaver CCW, de Knegt RJ, Luik AI, Nijsten TEC, Peeters RP, van Rooij FJA, Stricker BH, Uitterlinden AG, Vernooij MW, Voortman T. Objectives, design and main findings until 2020 from the Rotterdam Study. European Journal of Epidemiology. 2020;35(5):483-517. DOI: 10.1007/s10654-020-00640-5

View at:

Publisher Site: https://link.springer.com/article/10.1007/s10654-020-00640-5

PubMed: https://pubmed.ncbi.nlm.nih.gov/32367290/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250962/

GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 2020;396(10258):1223-1249. DOI: 10.1016/S0140-6736(20)30752-2

View at:

Publisher Site: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30752-2/fulltext

PubMed: https://pubmed.ncbi.nlm.nih.gov/33069327/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566194/

Viran SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, ... Tsao CW. Heart disease and stroke statistics – 2020 update: A report from the american heart association. Circulation. 2020;141(9):e139-e596. DOI: 10.1161/CIR.0000000000000757

View at:

Publisher Site: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000757

PubMed: https://pubmed.ncbi.nlm.nih.gov/31992061/

Virzì GM, Clementi A, Brocca A, Ronco C. Endotoxin effects on cardiac and renal functions and cardiorenal syndromes. Blood Purification. 2017;44(4):314-326. DOI: 10.1159/000480424

View at:

Publisher Site: https://www.karger.com/Article/FullText/480424

PubMed: https://pubmed.ncbi.nlm.nih.gov/29161706/

Li M, Gou Y, Yu H, Ji T, Li Y, Qin L, Sun W. Mechanism of metformin on lps-induced bacterial myocarditis. Dose-Response. 2019;17(2):1559325819847409. DOI: 10.1177/1559325819847409

View at:

Publisher Site: https://journals.sagepub.com/doi/10.1177/1559325819847409

PubMed: https://pubmed.ncbi.nlm.nih.gov/31205455/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537499/

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.